Nitrofurantoin
Nitrofurantoin

0.49
Relieves internal bladder irritation and targets urinary tract infections for Antibiotics by damaging bacterial DNA and ribosomal proteins to halt microbial replication.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Nitrofurantoin
Reference Brand
Macrodantin
Product Origin
Generic Product
Reference Manufacturer
Procter & Gamble
Product Form
Capsule, Tablet
Regulatory Classification
Rx
Primary Category
Antibiotics
Product Category
Nitrofuran
Pharmacological Class
Urinary antiseptic
Clinical Indications
Urinary tract infections
Manufacturer Description
Designed to manage bacterial infections specifically occurring within the urinary tract.
Mechanism of Action
Inhibits bacterial enzymatic systems, preventing the synthesis of proteins and DNA in the bacteria present in the urinary tract.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
6 hours
Contraindications
Kidney dysfunction
Severe Adverse Events
Lung damage, Liver toxicity
Common Side Effects
Nausea, Urine discoloration
Uncommon Side Effects
Stomach pain, Headache
Drug Interactions
Magnesium trisilicate
Pregnancy Safety Warnings
Safe in late pregnancy.
Age Restrictions
Consult doctor for pediatric use.
Storage Guidelines
Room temperature.
Related Products
Trimethoprim

Nitrofurantoin FAQ

How do digital health platforms facilitate evaluation and access to Nitrofurantoin in Singapore?

Digital health platforms provide a structured interface where individuals connect with clinical professionals for remote health assessments. These services manage the verification of medical necessity, ensuring that any support for Nitrofurantoin aligns with Singapore’s health regulations and clinical standards.

Why are there cost variations between multi-source generic Nitrofurantoin formulations and originator brands?

Formulation economics for generic Nitrofurantoin reflect the removal of original research and development expenses, prioritizing accessible delivery rather than brand-name premiums. Variations in price depend on manufacturing scale, distribution logistics, and quality assurance processes maintained by the producer.

How can patients in Singapore verify the regulatory compliance and sourcing standards of digital health directories providing Nitrofurantoin?

Verification of compliance involves reviewing the digital directory for clear documentation regarding regional health standards and operational transparency. Patients should confirm that the platform works with accredited facilitators that observe local laws concerning the distribution of medical compounds.

What are the logistical or regulatory considerations when utilizing cross-border facilitation for importing Nitrofurantoin into Singapore?

Importing specialized compounds into Singapore necessitates strict adherence to Health Sciences Authority (HSA) guidelines regarding personal imports of medical substances. Logistical considerations include the requirement for relevant documentation to prove medical necessity and compliance with customs regulations governing the movement of goods.

How does the clinical bioequivalence of generic Nitrofurantoin compare to the originator formula?

Generic Nitrofurantoin is manufactured to mirror the pharmacokinetic properties of the originator version, ensuring the active ingredient performs with identical clinical consistency. Bioequivalence testing confirms that the rate and extent of absorption remain within defined parameters, supporting the same therapeutic outcomes for the patient.

What is Nitrofurantoin?

Targeting bacterial infections within the urinary tract, Nitrofurantoin serves as a concentrated antimicrobial agent. Medical protocols categorize this compound as a nitrofuran antibiotic, specifically designed to address pathogenic microorganisms manifesting in bladder tissues. Healthcare providers often prioritize this substance for its localized activity within the urinary system.

Clinical utilization focuses on addressing bacterial growth that leads to discomfort and systemic imbalance. Patients encountering symptoms associated with uncomplicated urinary infections often find that this agent supports biological stability. Precise targeting of harmful bacteria ensures that the surrounding flora remains largely undisturbed during the therapeutic cycle.

Regulatory & Classification Profile

Regulatory frameworks within Singapore classify Nitrofurantoin as a Prescription-Only Medicine (POM). Access to this therapeutic agent requires clinical evaluation by a healthcare professional to ensure appropriateness for the indicated condition. Compliance with local health authority guidelines remains necessary for all distribution channels operating within the region.

Formulations & Associated Medications

Nitrofurantoin functions as a bioequivalent generic formulation containing the active ingredient Nitrofurantoin. Available formulations accessible through our website include Nitrofurantoin pill in strengths of 50mg and 100mg. These variations support specific clinical protocols intended to address urinary health requirements.

Therapeutic Applications

Managing acute cystitis represents the primary application for Nitrofurantoin. Addressing recurrent urinary tract infections helps stabilize the patient's internal environment. Preventing persistent bacterial colonization within the bladder assists in recovery. Reducing symptoms related to localized inflammation remains a core objective of the treatment. Target populations include non-pregnant adults and adolescents experiencing localized bacterial urinary distress.

Biological Action

Nitrofurantoin exerts activity by entering bacterial cells and undergoing reduction by microbial enzymes. Highly reactive intermediates generated during this internal process damage bacterial genetic material. Inhibition of protein synthesis and cellular wall components follows, effectively halting further microbial replication. Cellular metabolism within the bacteria declines rapidly, leading to the resolution of the infection.

Treatment Landscape & Drug Class

Nitrofurantoin belongs to the nitrofuran class of antibiotics. Modern clinical protocols frequently utilize this chemical family for its specific affinity for urinary site infections. Compounds within this classification remain essential tools for managing bacterial presence without broad-spectrum disruption of the gastrointestinal microbiome.

Understanding the Safety Profile

Physiological processing of Nitrofurantoin occurs primarily through rapid absorption and subsequent renal excretion, which concentrates the active agent in the urine. Hepatic and renal systems handle the metabolic clearance of the compound, requiring standard monitoring of organ function during extended use. Nervous system sensitivity can occur in rare instances depending on the duration of the cycle. Refer to the clinical data tables provided for specific contraindications, interactions, and potential reactions.

Clinical Disclosure

Educational oversight regarding Nitrofurantoin provides a broad context for understanding its role in antimicrobial therapy. Medicines like Nitrofurantoin differ in strength based on individual clinical assessments and formulation requirements. Responsibility for health outcomes remains with the overseeing healthcare professional rather than digital information platforms. Always consult specific product labeling and a qualified healthcare professional before beginning any therapeutic intervention to ensure safety and clinical alignment with individual health needs.

Clinical Glossary

Antibiotic
A substance used to inhibit the growth of, or destroy, microorganisms.
Bioequivalent
A state where two products containing the same active ingredient demonstrate similar therapeutic effects and biological availability.
Cystitis
An inflammatory condition affecting the bladder, typically caused by bacterial infiltration.
Urinary Tract
The biological system responsible for the storage and elimination of liquid waste, including the bladder and urethra.
Information associated with Nitrofurantoin is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
Categories